Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Does treatment with antidepressant medication increase suicidal behavior?

M J Goldblatt1, A F Schatzberg

  • 1Affective Disease Program, McLean Hospital, Belmont, MA 02178.

International Clinical Psychopharmacology
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cognitive effects of mifepristone in overweight, euthymic adults with depressive disorders.

Journal of affective disorders·2018
Same author

Quantitative validation of immunofluorescence and lectin staining using reduced CLARITY acrylamide formulations.

Brain structure & function·2017
Same author

Variable telomere length across post-mortem human brain regions and specific reduction in the hippocampus of major depressive disorder.

Translational psychiatry·2016
Same author

HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition.

Molecular psychiatry·2016
Same author

Anhedonia and general distress show dissociable ventromedial prefrontal cortex connectivity in major depressive disorder.

Translational psychiatry·2016
Same author

Childhood trauma predicts antidepressant response in adults with major depression: data from the randomized international study to predict optimized treatment for depression.

Translational psychiatry·2016
Same journal

Critical reassessment of manic and psychotic episodes related to levetiracetam: a systematic review of published case reports.

International clinical psychopharmacology·2026
Same journal

Expanding the horizon of brexpiprazole augmentation in treatment-resistant disorders: from obsessive-compulsive disorder to adolescent bipolar disorder.

International clinical psychopharmacology·2026
Same journal

Acceptability-adjusted speed in psychotic agitation: interpreting pro re nata antipsychotic data in real-world care (commentary on Hatta et al.).

International clinical psychopharmacology·2026
Same journal

Antipsychotics in clinical practice: agitation, polypharmacy, and treatment resistance.

International clinical psychopharmacology·2026
Same journal

Methylphenidate treatment in adults with comorbid attention-deficit/hyperactivity disorder and borderline personality disorder: a prospective longitudinal study.

International clinical psychopharmacology·2026
Same journal

Association between anxious depression and clinical outcomes in subjects with treatment-resistant depression: a comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment-resistant depression (ASCERTAIN-TRD).

International clinical psychopharmacology·2026
See all related articles

Major depression patients face high suicide risks. While antidepressants aid recovery, some may paradoxically increase suicidal behavior risk, particularly impacting the serotonin system.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Pharmacology

Background:

  • Suicidal ideation and behavior are strongly linked to psychiatric conditions, especially affective disorders.
  • Major Depressive Disorder (MDD) patients have a significant lifetime suicide risk (15-30%).
  • The psychobiology of suicide, particularly the role of serotonin, is gaining research attention.

Purpose of the Study:

  • To review the role of serotonin in suicidal behavior in depression.
  • To examine the debate surrounding antidepressants potentially adversely affecting suicidal behavior in depressed patients.
  • To discuss potential mechanisms involving the serotonergic system and provide a framework for interpreting clinical data.

Main Methods:

  • Literature review of studies on serotonin and suicidal behavior.

Related Experiment Videos

  • Analysis of the debate on antidepressant adverse effects on suicidal behavior.
  • Discussion of potential psychobiological mechanisms.

    • Main Results:

    • Serotonin is implicated in suicidal behavior, especially in depressed individuals.
    • Antidepressant treatment generally improves outcomes but can sometimes have adverse effects on suicidal behavior.
    • The exact nature and mechanisms of these adverse effects remain a subject of debate.

    Conclusions:

    • Understanding the complex relationship between serotonin, depression, and antidepressant treatment is crucial.
    • Further research is needed to elucidate the mechanisms behind antidepressants potentially increasing suicidal behavior.
    • A contextual framework is proposed for interpreting clinical data on this phenomenon.